C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2011
11/17/2011	US20110281295 Method and device for culturing algae
11/17/2011	US20110281294 Method and device for measuring adhesion forces
11/17/2011	US20110281293 Preparation and its use of derivatization reagent for detecting l-carnitine or d-carnitine
11/17/2011	US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011	US20110281291 Identification and/or characterization of a microbial agent using taxonomic hierarchical classification
11/17/2011	US20110281290 Sox-based kinase sensor
11/17/2011	US20110281289 Quantification of enzyme activity by mass spectrometry using immobilized substrates
11/17/2011	US20110281288 Reusable Nanowire Field Effect Transistor System for Detecting Biomolecular Interactions
11/17/2011	US20110281287 Size self-limiting compositions and test devices for measuring analytes in biological fluids
11/17/2011	US20110281286 Expression vector for establishing highly productive cell and the highly productive cell
11/17/2011	US20110281282 Subpopulations of spore-like cells and uses thereof
11/17/2011	US20110281279 CIRCULATING Epha2 RECEPTOR
11/17/2011	US20110281278 High Throughput Assay for Discovering New Inhibitors of the GIRK1/4 Channel
11/17/2011	US20110281277 Composition, kit, and method for diagnosing colorectal cancer or ovarian cancer
11/17/2011	US20110281276 Nucleic acid-free thermostable enzymes and methods of production thereof
11/17/2011	US20110281275 Primers for nucleic acid amplification in detecting beta-actin and test method using these primers
11/17/2011	US20110281274 Cosmetic use of an active agent capable of stimulating tensin 1 expression
11/17/2011	US20110281273 Method of making dna tag
11/17/2011	US20110281272 Processing and analysis of viscous liquid biological samples
11/17/2011	US20110281271 Oligoribonucleotide or Peptide Nucleic Acid Capable of Inhibiting Activity of Hepatitis C Virus
11/17/2011	US20110281270 Efficient detection of double mutants of the cebpa gene in acute myeloid leukemia
11/17/2011	US20110281269 Isolation and characterization of a single mitochondrion
11/17/2011	US20110281268 Circulating microrna as a marker for hepatocellular carcinoma
11/17/2011	US20110281267 Functionalized microfluidic device for immunofluorescence
11/17/2011	US20110281266 Identification of Nucleic Acids
11/17/2011	US20110281265 Primer set for amplifying UGT1A1 gene, reagent for amplifying UGT1A1 gene containing the same, and the uses thereof
11/17/2011	US20110281264 Method for diagnosing and predicting cerebellar ataxia
11/17/2011	US20110281263 Compositions and Methods for Detection of Chromosomal Aberrations with Novel Hybridization Buffers
11/17/2011	US20110281262 Detection of germs associated with periodontitis
11/17/2011	US20110281261 Vectors
11/17/2011	US20110281260 Ribonucleic acid binding motif protein 20 sequence variants
11/17/2011	US20110281259 Method And Apparatus For the Simultaneous, Automated Decomposition Of A Plurality Of Biological Samples
11/17/2011	US20110281258 Human Immunodeficiency Virus And Uses Thereof
11/17/2011	US20110281257 Method for producing beta-santalene
11/17/2011	US20110281256 Systems and Methods of Detecting and Demonstrating Hair Damage Via Evaluation of Protein Fragments
11/17/2011	US20110280940 Di-Vanilloyl And Tri-Vanilloyl Derivatives For Use In Anti-Cancer Therapy
11/17/2011	US20110280914 Hydrogels crosslinked with gold nanoparticles and methods of making and using thereof
11/17/2011	US20110280913 Methods and Compositions for Delivering Therapeutic Agents in the Treatment of B-Cell Related Disorders
11/17/2011	US20110280901 Diagnosis and treatment of Trypanosoma cruzi infection and chagas disease
11/17/2011	US20110280887 Methods for diagnosis of cardiovascular disease
11/17/2011	US20110280886 Treating cancer by modulating mnk
11/17/2011	US20110280865 Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof
11/17/2011	US20110280844 Hepatocyte production by forward programming
11/17/2011	US20110280809 Pdia4, target of cytopiloyne derivatives, for tumor diagnosis and treatment
11/17/2011	US20110278167 Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
11/17/2011	US20110277991 Methods of identifying stimulants for methane production from hydrocarbon-bearing formations
11/17/2011	DE102011018627A1 Modifizierte Nucleotide Modified nucleotides
11/17/2011	DE102010010372B3 Kit, useful e.g. for identification of pathogens of Mycobacterium tuberculosis complexes, comprises means for analyzing sequences in genes Rv0557, Rv2628, Rv2629 and Rv1811, and the promoter sequence of Rv2946c
11/17/2011	DE102010007243B4 Therapieoptimierung bei Krebspatienten durch Austesten von Therapiekombinationen mittels in vitro Testungen (Zusatz) Optimizing therapy for cancer patients by testing combinations of therapy by in vitro tests (additional)
11/17/2011	DE102009044085A1 Verfahren zur in vitro Erfassung und Unterscheidung von pathophysiologischen Zuständen Method for the in vitro detection and discrimination of pathophysiological conditions
11/17/2011	CA2834108A1 Screening assays based on mag and/or abhd6 for selecting insulin secretion promoting agents
11/17/2011	CA2800610A1 Differentiation of human embryonic stem cells
11/17/2011	CA2799420A1 Compositions and methods for treating neoplasia, inflammatory disease and other disorders
11/17/2011	CA2799416A1 Compositions and methods for targeting a3g:rna complexes
11/17/2011	CA2799403A1 Compositions and methods for treating leukemia
11/17/2011	CA2799351A1 Methods and devices for diagnosing alzheimers disease
11/17/2011	CA2799177A1 Enhanced death receptor agonists
11/17/2011	CA2799165A1 Diagnostic markers for neuropsychiatric disease
11/17/2011	CA2799028A1 Method of creating and sorting fused cells
11/17/2011	CA2798895A1 Modulation of splenocytes in cell therapy
11/17/2011	CA2798434A1 Discrete states for use as biomarkers
11/17/2011	CA2797539A1 Methods of diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in felines
11/17/2011	CA2795226A1 Use of brown midrib-3 gene specific markers in maize for trait introgression
11/17/2011	CA2788821A1 Isothermal amplification of nucleic acid using primers comprising a randomized sequence and specific primers and uses thereof
11/16/2011	EP2386969A2 Self-improving classification system
11/16/2011	EP2386860A2 Predicting mortality and detecting severe disease
11/16/2011	EP2386859A2 Diagnostic tumor markers
11/16/2011	EP2386659A2 Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods of Detection and Uses Thereof
11/16/2011	EP2386658A2 Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods of Detection and Uses Thereof
11/16/2011	EP2386657A2 Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods of Detection and Uses Thereof
11/16/2011	EP2386656A2 Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods of Detection and Uses Thereof
11/16/2011	EP2386655A2 Methods and compositions for the diagnosis and treatment of lung cancer using KIT or KDG gene as genetic marker
11/16/2011	EP2386654A1 DNA Methylation markers associated with the CpG island methylator phenotype (cimp) in human colorectal cancer
11/16/2011	EP2386653A2 Methods for the utilization of novel target genes related to immune-mediated diseases
11/16/2011	EP2386652A1 Homogeneous method for determining the plasminogen activator activating activity of the FSAP
11/16/2011	EP2386651A1 Method for screening for salty taste control substance
11/16/2011	EP2386637A2 MicroRNA molecules
11/16/2011	EP2386631A1 Purified lipase, methods of modification and applications
11/16/2011	EP2386615A1 Pressure-sensitive adhesive sheet
11/16/2011	EP2386060A2 Sample collection and measurement in a single container by back scattering interferometry
11/16/2011	EP2385993A1 Genetic analysis of cells
11/16/2011	EP2385992A2 Enrichment and identification of fetal cells in maternal blood and ligands for such use
11/16/2011	EP2385991A1 Nucleic acid amplification with allele-specific suppression of sequence variants
11/16/2011	EP2385990A2 Real time polymerase chain reaction detection of legionella pneumophila and differentiation from other legionella species
11/16/2011	EP2385989A1 Genetic variants useful for risk assessment of thyroid cancer
11/16/2011	EP2385988A1 Rapid bioluminescence detection system
11/16/2011	EP2385987A2 Method for improving biomass yield
11/16/2011	EP2385979A1 Sequence-specific large volume sample preparation method and assay
11/16/2011	EP2385756A1 Soybean event 127 and methods related thereto
11/16/2011	EP2271778B1 Method for detection of herpesvirus in a test sample
11/16/2011	EP2171094B1 Mipol1-etv1 gene rearrangements
11/16/2011	EP2057276B1 Assay method for the detection of viable microbial cells in a sample
11/16/2011	EP1976871B1 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same
11/16/2011	EP1874951B1 Test media and method for identification and differentiation of bacteria
11/16/2011	EP1863925B1 Method of predicting the clinical response to platinum based chemotherapeutic treatment
11/16/2011	EP1718756B1 Botulinum toxin screening assays
11/16/2011	EP1664102B1 Isolated photoprotein mtclytin, and use thereof
11/16/2011	EP1583846B1 Circulating mrna as diagnostic markers for pregnancy-related disorders
11/16/2011	EP1553980B1 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
11/16/2011	EP1507868B1 Quality assays for antigen presenting cells

1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 3003